PHASE-II STUDY OF RECOMBINANT ALPHA-INTERFERON AND RECOMBINANT INTERLEUKIN-2 IN METASTATIC BREAST-CANCER

被引：3
|
作者：
WALTERS, RS
THERIAULT, RL
HOLMES, FA
ESPARZA, L
HORTOBAGYI, GN
机构：
[1] Department of Breast and Gynecologic Medical Oncology, Division of Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX
来源：
JOURNAL OF IMMUNOTHERAPY | 1994年 / 16卷 / 04期
关键词：
INTERFERON; INTERLEUKIN-2; METASTATIC BREAST CANCER;
D O I：
10.1097/00002371-199411000-00008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Ten patients with metastatic breast cancer were treated with a combination of recombinant alpha-interferon and recombinant interleukin-2. The toxicity of treatment was considerable, including one death on therapy. No objective responses were seen.
引用
收藏
页码：303 / 305
页数：3
相关论文
共 50 条
  • [21] A PHASE-I STUDY OF SUBCUTANEOUS RECOMBINANT INTERLEUKIN-2 AND INTERFERON ALFA-2A
    RATAIN, MJ
    PRIEST, ER
    JANISCH, L
    VOGELZANG, NJ
    CANCER, 1993, 71 (07) : 2371 - 2376
  • [22] PHASE-II EVALUATION OF RECOMBINANT INTERFERON-ALPHA-2A AND CONTINUOUS INFUSION FLUOROURACIL IN PREVIOUSLY UNTREATED METASTATIC COLORECTAL ADENOCARCINOMA
    PAZDUR, R
    AJANI, JA
    PATT, YZ
    GOMEZ, J
    BREADY, B
    LEVIN, B
    CANCER, 1993, 71 (04) : 1214 - 1218
  • [23] An outpatient phase II study of subcutaneous interleukin-2 and interferon-alpha-2b in combination with intravenous vinblastine in metastatic renal cell cancer
    Pectasides, D
    Varthalitis, J
    Kostopoulou, M
    Mylonakis, A
    Triantaphyllis, D
    Papadopoulou, M
    Dimitriadis, M
    Athanassiou, A
    ONCOLOGY, 1998, 55 (01) : 10 - 15
  • [24] PHASE-II TRIAL OF CARBOPLATIN AND ETOPOSIDE IN METASTATIC BREAST-CANCER
    CROWN, J
    HAKES, T
    REICHMAN, B
    LEBWOHL, D
    GILEWSKI, T
    SURBONE, A
    CURRIE, V
    YAO, TJ
    HUDIS, C
    SEIDMAN, A
    NORTON, L
    CANCER, 1993, 71 (04) : 1254 - 1257
  • [25] A PHASE-II TRIAL OF VINORELBINE AND THIOTEPA IN METASTATIC BREAST-CANCER
    FABI, A
    TONACHELLA, R
    SAVARESE, A
    CIRULLI, S
    TOMAO, S
    CONTE, E
    COGNETTI, F
    ANNALS OF ONCOLOGY, 1995, 6 (02) : 187 - 189
  • [26] Cisplatin, interleukin-2, interferon-α and tamoxifen in metastatic melanoma.: A phase II study
    Naglieri, E
    Procacci, A
    Galetta, D
    Abbate, I
    Dell'Erba, L
    Colucci, G
    JOURNAL OF CHEMOTHERAPY, 1999, 11 (02) : 150 - 155
  • [27] A phase II trial of interleukin-2 and interferon-alpha in the treatment of metastatic colorectal carcinoma
    Chang, AE
    Cameron, MJ
    Sondak, VK
    Geiger, JD
    VanderWoude, DL
    JOURNAL OF IMMUNOTHERAPY, 1995, 18 (04): : 253 - 262
  • [28] PHASE-I TRIAL OF RECOMBINANT INTERLEUKIN-2 FOLLOWED BY RECOMBINANT TUMOR-NECROSIS-FACTOR IN PATIENTS WITH METASTATIC CANCER
    NEGRIER, MS
    POURREAU, CN
    PALMER, PA
    RANCHERE, JY
    MERCATELLO, A
    VIENS, P
    BLAISE, D
    JASMIN, C
    MISSET, JL
    FRANKS, CR
    MARANINCHI, D
    PHILIP, T
    JOURNAL OF IMMUNOTHERAPY, 1992, 11 (02): : 93 - 102
  • [29] PHASE-II STUDY OF LOW-DOSE CYCLOPHOSPHAMIDE AND INTRAVENOUS INTERLEUKIN-2 IN METASTATIC RENAL-CANCER
    QUAN, WDY
    DEAN, GE
    LIESKOVSKY, G
    MITCHELL, MS
    KEMPF, RA
    INVESTIGATIONAL NEW DRUGS, 1994, 12 (01) : 35 - 39
  • [30] Cyclosporine A, alpha-interferon and interleukin-2 following chemotherapy with BCNU, DTIC, cisplatin, and tamoxifen: A phase II study in advanced melanoma
    Feun, L
    Marini, A
    Moffat, F
    Savaraj, N
    Hurley, J
    Mazumder, A
    CANCER INVESTIGATION, 2005, 23 (01) : 3 - 8
12345